Open AccessLow recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
Author(s) -
Marco Vivarelli,
R Bellusci,
Alessandro Cucchetti,
Giulia Cavrini,
N. De Ruvo,
Ardo Abdiueli Aden,
Giuliano La Barba,
Stefano Brillanti,
Antonino Cavallari
Publication year - 2002
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200212270-00017
Subject(s) - immunosuppression , medicine , hepatocellular carcinoma , liver transplantation , surgery , transplantation , gastroenterology
Liver transplantation is currently offered to a limited number of patients with hepatocellular carcinoma (HCC) because of strict criteria introduced in the past to avoid recurrence. Immunosuppression represents a risk factor for tumor growth; the schedules of the immunosuppressant drugs have been modified through the years, aiming to reduce their dosage to the effective minimum.